Shinji Kobuchi

9PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)PharmacogenomicsHaematological tumoursMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2024
Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans.

Shinji Kobuchi, Mayuka Arimoto, Yukako Ito

|Nov 25, 2023
Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer.

Yukako Ito, Shinji Kobuchi, Amiri Kawakita

|Jul 11, 2022
Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant Staphylococcus aureus agents using a rat model of sepsis.

Shinji Kobuchi, Naoya Kanda, Taichi Okumi

|Feb 26, 2022
Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus.

Tetsuo Hayakawa, Ken-Ichiro Kato, Shinji Kobuchi

|Dec 24, 2021
Population Pharmacokinetic Model-Based Evaluation of Intact Oxaliplatin in Rats with Acute Kidney Injury.

Shinji Kobuchi, Miyu Kai, Yukako Ito

|Jun 04, 2020
A validated LC-MS/MS method for the low-level determination of pemafibrate, a novel SPPARMĪ±, in plasma.

Shinji Kobuchi, Atsushi Shigemura, Yukako Ito

Pageof 2

Frequent Collaborators

1 joint publications

Akihiro Tamiya